A detailed history of Nisa Investment Advisors, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 639 shares of LUNG stock, worth $1,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
639
Previous 66 868.18%
Holding current value
$1,124
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$1.51 - $3.78 $865 - $2,165
573 Added 868.18%
639 $1,000
Q2 2025

Jul 31, 2025

SELL
$2.57 - $6.87 $4,271 - $11,417
-1,662 Reduced 96.18%
66 $0
Q1 2025

Apr 30, 2025

BUY
$5.68 - $9.22 $1,295 - $2,102
228 Added 15.2%
1,728 $11,000
Q4 2024

Jan 17, 2025

SELL
$5.93 - $7.71 $931 - $1,210
-157 Reduced 9.47%
1,500 $10,000
Q3 2024

Oct 24, 2024

BUY
$5.59 - $8.58 $391 - $600
70 Added 4.41%
1,657 $13,000
Q2 2024

Jul 19, 2024

BUY
$5.77 - $9.82 $8,960 - $15,250
1,553 Added 4567.65%
1,587 $10,000
Q4 2023

Jan 25, 2024

SELL
$7.89 - $13.14 $16,411 - $27,331
-2,080 Reduced 98.39%
34 $0
Q3 2023

Nov 02, 2023

BUY
$9.88 - $14.0 $98 - $140
10 Added 0.48%
2,114 $21,000
Q2 2023

Aug 11, 2023

BUY
$10.78 - $13.65 $3,988 - $5,050
370 Added 21.34%
2,104 $27,000
Q1 2023

May 02, 2023

BUY
$7.49 - $12.54 $12,733 - $21,318
1,700 Added 5000.0%
1,734 $19,000
Q4 2022

Feb 02, 2023

SELL
$4.92 - $17.35 $4 - $17
-1 Reduced 2.86%
34 $0
Q3 2022

Nov 07, 2022

BUY
$15.35 - $23.99 $537 - $839
35 New
35 $0
Q2 2022

Aug 03, 2022

SELL
$14.0 - $27.95 $9,800 - $19,565
-700 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$21.13 - $35.65 $16,904 - $28,520
-800 Reduced 53.33%
700 $17,000
Q4 2021

Feb 03, 2022

BUY
$29.72 - $45.1 $44,580 - $67,650
1,500 New
1,500 $37,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $65.6M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.